(redirected from diabetes mellitus)
Also found in: Dictionary, Thesaurus, Medical, Legal, Acronyms, Encyclopedia, Wikipedia.

DM (1)

The two-character ISO 3166 country code for DOMINICA.

DM (2)

Deutsche marks, the former currency of Germany.


1. ISO 3166-1 alpha-2 code for the Commonwealth of Dominica. This is the code used in international transactions to and from Dominican bank accounts.

2. ISO 3166-2 geocode for Dominica. This is used as an international standard for shipping to Dominica. Each parish has its own code with the prefix "DM." For example, the code for the Parish of St. Joseph is ISO 3166-2:DM-06.
References in periodicals archive ?
Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance.
Risk of development of diabetes mellitus after diagnosis of gestational diabetes.
Thus, the IFCC and other similar organizations must find ways to implement these sensible recommendations in the clinical setting, for all patients with or evaluated for diabetes mellitus.
An epidemic of type 2 diabetes mellitus is currently underway in the United States.
Pathologically, macro-vascular disease in diabetes mellitus is an indication of arteriosclerosis, which is the deposit of materials within the inner layer in the intima of the vessel walls.
Other patients, including those with diabetes mellitus, may have neuropathic complications that cause loss of sensation in the legs.
The array of entities called diabetes mellitus is the abnormality of glucose intolerance and the potential for developing complications from altered glucose and lipid metabolism.
The second section reviews the definition, classification, and diagnostic criteria for diabetes as formulated in 1985 by the WHO study group on diabetes mellitus.
com/research/9ssmhp/global_diabetes) has announced the addition of the "Global Diabetes Mellitus - Type 1 Drug Pipeline Capsule - 2012 Update" report to their offering.
Diabetes Mellitus Drug Clinical Pipeline by Company & Phase - Phase Research to till Registered - Marketed Drug Clinical Insight
announced today that Mitsubishi Tanabe Pharma has received approval to manufacture and market the SGLT2 inhibitor, CANAGLUA tablets 100mg (generic name: canagliflozin hydrate, hereafter, CANAGLUA) in Japan, for the treatment of patients with type 2 diabetes mellitus.

Full browser ?